Mark Walport

32.2k total citations · 6 hit papers
319 papers, 22.7k citations indexed

About

Mark Walport is a scholar working on Immunology, Rheumatology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mark Walport has authored 319 papers receiving a total of 22.7k indexed citations (citations by other indexed papers that have themselves been cited), including 175 papers in Immunology, 86 papers in Rheumatology and 68 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mark Walport's work include Complement system in diseases (95 papers), Systemic Lupus Erythematosus Research (78 papers) and Monoclonal and Polyclonal Antibodies Research (64 papers). Mark Walport is often cited by papers focused on Complement system in diseases (95 papers), Systemic Lupus Erythematosus Research (78 papers) and Monoclonal and Polyclonal Antibodies Research (64 papers). Mark Walport collaborates with scholars based in United Kingdom, United States and Switzerland. Mark Walport's co-authors include Marina Botto, H. Terence Cook, Kevin Davies, Anne E. Bygrave, Matthew C. Pickering, John Savill, Philip R. Taylor, A H Wyllie, P M Henson and J E Henson and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Mark Walport

314 papers receiving 22.0k citations

Hit Papers

Complement 1989 2026 2001 2013 2001 1989 1998 2001 2000 500 1000 1.5k 2.0k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Mark Walport 14.4k 5.3k 3.8k 3.3k 2.7k 319 22.7k
Paul I. Terasaki 13.3k 0.9× 3.2k 0.6× 3.4k 0.9× 3.8k 1.1× 2.4k 0.9× 620 34.9k
B. Paul Morgan 15.0k 1.0× 1.4k 0.3× 6.5k 1.7× 3.5k 1.0× 2.4k 0.9× 620 28.1k
Thomas Dörner 10.5k 0.7× 7.2k 1.4× 2.7k 0.7× 1.6k 0.5× 4.3k 1.6× 371 19.2k
John P. Atkinson 8.7k 0.6× 996 0.2× 2.8k 0.8× 3.3k 1.0× 1.6k 0.6× 300 16.3k
Lars Klareskog 13.8k 1.0× 22.1k 4.2× 6.1k 1.6× 5.1k 1.5× 8.0k 3.0× 657 42.3k
Olivier Hermine 11.9k 0.8× 2.1k 0.4× 7.1k 1.9× 3.8k 1.1× 527 0.2× 822 29.8k
Michael E. Weinblatt 7.4k 0.5× 17.2k 3.2× 4.9k 1.3× 7.9k 2.4× 2.8k 1.1× 381 33.9k
Elaine S. Jaffe 15.2k 1.1× 3.4k 0.6× 8.6k 2.3× 5.8k 1.7× 2.5k 1.0× 720 63.1k
Ronald J. Falk 7.0k 0.5× 6.7k 1.3× 4.2k 1.1× 1.2k 0.4× 719 0.3× 343 26.1k
Philip N. Hawkins 3.7k 0.3× 4.1k 0.8× 25.9k 6.9× 3.0k 0.9× 2.8k 1.0× 556 33.6k

Countries citing papers authored by Mark Walport

Since Specialization
Citations

This map shows the geographic impact of Mark Walport's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Walport with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Walport more than expected).

Fields of papers citing papers by Mark Walport

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Walport. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Walport. The network helps show where Mark Walport may publish in the future.

Co-authorship network of co-authors of Mark Walport

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Walport. A scholar is included among the top collaborators of Mark Walport based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Walport. Mark Walport is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carlucci, Francesco, Liliane Fossati‐Jimack, Ingrid E. Dumitriu, et al.. (2010). Identification and Characterization of a Lupus Suppressor 129 Locus on Chromosome 3. The Journal of Immunology. 184(11). 6256–6265. 11 indexed citations
2.
Carlucci, Francesco, Josefina Cortés-Hernández, Liliane Fossati‐Jimack, et al.. (2007). Genetic Dissection of Spontaneous Autoimmunity Driven by 129-Derived Chromosome 1 Loci When Expressed on C57BL/6 Mice. The Journal of Immunology. 178(4). 2352–2360. 54 indexed citations
3.
Ferry, Helen, Paul Potter, Tanya L. Crockford, et al.. (2007). Increased Positive Selection of B1 Cells and Reduced B Cell Tolerance to Intracellular Antigens in c1q-Deficient Mice. The Journal of Immunology. 178(5). 2916–2922. 27 indexed citations
4.
Pickering, Matthew C., Joanna Warren, Kamala Rose, et al.. (2006). Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice. Proceedings of the National Academy of Sciences. 103(25). 9649–9654. 120 indexed citations
5.
Manderson, Anthony P., Ben Quah, Marina Botto, et al.. (2006). A Novel Mechanism for Complement Activation at the Surface of B Cells Following Antigen Binding. The Journal of Immunology. 177(8). 5155–5162. 7 indexed citations
6.
Norsworthy, Peter J., Liliane Fossati‐Jimack, Josefina Cortés-Hernández, et al.. (2004). Murine CD93 (C1qRp) Contributes to the Removal of Apoptotic Cells In Vivo but Is Not Required for C1q-Mediated Enhancement of Phagocytosis. The Journal of Immunology. 172(6). 3406–3414. 116 indexed citations
7.
Potter, Paul, Josefina Cortés-Hernández, Pierre Quartier, Marina Botto, & Mark Walport. (2003). Lupus-Prone Mice Have an Abnormal Response to Thioglycolate and an Impaired Clearance of Apoptotic Cells. The Journal of Immunology. 170(6). 3223–3232. 142 indexed citations
8.
Vandivier, R. William, Carol Anne Ogden, Valerie A. Fadok, et al.. (2002). Role of Surfactant Proteins A, D, and C1q in the Clearance of Apoptotic Cells In Vivo and In Vitro: Calreticulin and CD91 as a Common Collectin Receptor Complex. The Journal of Immunology. 169(7). 3978–3986. 420 indexed citations
9.
Botto, Marina, et al.. (2001). AA amyloid deposition is complement independent. UCL Discovery (University College London). 1 indexed citations
11.
Petry, Franz, Marina Botto, Rafaela Holtappels, Mark Walport, & Michael Loos. (2001). Reconstitution of the Complement Function in C1q-Deficient (C1qa−/−) Mice with Wild-Type Bone Marrow Cells. The Journal of Immunology. 167(7). 4033–4037. 96 indexed citations
12.
Pickering, Matthew C., et al.. (2001). Ultraviolet-Radiation-Induced Keratinocyte Apoptosis in C1q-Deficient Mice. Journal of Investigative Dermatology. 117(1). 52–58. 34 indexed citations
13.
Cutler, Antony J., Richard J. Cornall, H. E. Street, Marina Botto, & Mark Walport. (1999). B cell tolerance is intact in C1q deficient mice. Molecular Immunology. 36. 288–288. 1 indexed citations
14.
Barakat, Maha T, Jason Scott, Mark Walport, et al.. (1996). Grand Rounds—Hammersmith Hospital: Persistent fever in pulmonary tuberculosis. BMJ. 313(7071). 1543–1545. 9 indexed citations
15.
Savill, John, A H Wyllie, J E Henson, et al.. (1989). Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages.. Journal of Clinical Investigation. 83(3). 865–875. 1303 indexed citations breakdown →
16.
Englert, H., S. Loizou, G. Derue, Mark Walport, & Graham R.V. Hughes. (1989). Clinical and immunologic features of livedo reticularis in lupus: A case-control study. The American Journal of Medicine. 87. 408–410. 5 indexed citations
17.
Schifferli, Jürg A., Y C Ng, J Estreicher, & Mark Walport. (1988). The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms.. The Journal of Immunology. 140(3). 899–904. 123 indexed citations
18.
Englert, H., S. Loizou, G R Hughes, V R Aber, & Mark Walport. (1986). Livedo reticularis and lupus erythematosus clinical and immunological associations. Lara D. Veeken. 1 indexed citations
20.
Walport, Mark, W N Hubbard, & Graham R.V. Hughes. (1982). Reversal of aplastic anaemia secondary to systemic lupus erythematosus by high-dose intravenous cyclophosphamide. BMJ. 285(6344). 769–770. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026